Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001232524-25-000014
Filing Date
2025-04-25
Accepted
2025-04-25 16:09:18
Documents
23
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A jazz-20241231.htm   iXBRL 10-K/A 1263052
2 EX-31.3 jazz10-kafy2024exhibit313.htm EX-31.3 5780
3 EX-31.4 jazz10-kafy2024exhibit314.htm EX-31.4 5462
7 GRAPHIC jazz-20241231_g1.jpg GRAPHIC 18757
8 GRAPHIC jazz-20241231_g2.jpg GRAPHIC 18559
9 GRAPHIC jazz-20241231_g3.jpg GRAPHIC 18114
10 GRAPHIC jazz-20241231_g4.jpg GRAPHIC 61249
11 GRAPHIC jazz-20241231_g5.jpg GRAPHIC 66566
  Complete submission text file 0001232524-25-000014.txt   2385261

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jazz-20241231.xsd EX-101.SCH 2532
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jazz-20241231_lab.xml EX-101.LAB 139116
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jazz-20241231_pre.xml EX-101.PRE 75277
26 EXTRACTED XBRL INSTANCE DOCUMENT jazz-20241231_htm.xml XML 11169
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33500 | Film No.: 25874007
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)